Translational Development Acquisition Corp. Ordinary Shares (TDAC) — Cash Flow Quality Index
Latest as of September 2025:
-0.75x
Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Cash Flow Quality Index of -0.75x as of September 2025. Operating cash flow of $-1.24 Million is below net income of $1.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TDAC operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
-0.75x
Operating CF / Net Income
Operating Cash Flow
$-1.24 Million
USD
Net Income
$1.66 Million
USD
Data as of
Sep 2025
Most recent filing
Annual Cash Flow Quality Index for Translational Development Acquisition Corp. Ordinary Shares (None–None)
Year-by-year earnings quality comparison for Translational Development Acquisition Corp. Ordinary Shares. For live market cap and the full company financial profile, see market cap of Translational Development Acquisition Co.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.